查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年臨床試驗生物儲存庫和存檔解決方案市場規模、份額、趨勢分析報告（按服務（存檔解決方案、生物儲存服務）、副產品（臨床前、臨床）、階段（II、III）、分部預測）
市場調查報告書
商品編碼
1233157

2023-2030 年臨床試驗生物儲存庫和存檔解決方案市場規模、份額、趨勢分析報告（按服務（存檔解決方案、生物儲存服務）、副產品（臨床前、臨床）、階段（II、III）、分部預測）

Clinical Trial Biorepository & Archiving Solutions Market Size, Share & Trends Analysis Report By Service (Archiving Solution, Biorepository Services), By Product (Preclinical, Clinical), By Phase (II, III), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

臨床試驗生物樣本庫和存檔解決方案的市場增長和趨勢

根據 Grand View Research, Inc. 的一份新報告，全球臨床試驗生物樣本庫和歸檔解決方案市場規模從 2023 年到 2030 年的複合年增長率將達到 8.3%，預計2030 年將達到 70 億美元。

這主要是由於生物樣本管理在臨床試驗中的重要性與日俱增，並且需要更高效的數據收集和報告。 此外，隨著精準醫學、個性化醫學和基因組醫學的擴展，研發支出的增加，採用實驗室資訊管理系統（LIMS）等軟件來管理實驗室樣本有助於數據收集和報告。努力促進行業的發展是推動行業發展的主要因素。

多個監管機構建議並製定運營生物樣本庫的最佳實踐。 國際生物環境儲存協會正在加強其在全球範圍內標準化生物儲存程序的地位。 美國病理學家協會建立了第一個符合嚴格法規的生物樣本庫認證計劃，以標準化生物樣本庫實踐。 國際標準化組織 (ISO-20387) 已經發布了關於生物保存能力、公正性和一致性操作的生物儲存庫標準。

美國FDA制定了GMP（良好生產規範）、GLP（良好實驗室規範）、GDP和GTP（良好組織規範），其中包括與藥品包裝和儲存相關的要素。 COVID-19 大流行還為當地企業創造了多個增長機會。 為了鞏固在行業中的立足點，各大公司正在採取各種計劃和政策，以在全球市場上獲得更大的收入份額。 領先公司已將與相關第三方供應商的合作確定為關鍵步驟。 這可以通過適當溝通和協調臨床試驗生物儲存庫和存檔解決方案的頻率和數量來實現。

臨床試驗生物儲存庫和存檔解決方案市場報告要點

  • 個性化醫療等先進療法的研發增加，以及對用於樣本採集、處理、測試和存儲的高質量生物樣本庫實踐的需求，導致生物樣本庫服務領域在 2022 年佔據行業主導地位。
  • 按階段劃分，III 期細分市場預計將在 2022 年主導行業，而 II 期細分市場預計將在 2023 年至 2030 年實現最快的複合年增長率。
  • 臨床產品部分將在 2022 年佔據最大份額，因為大多數臨床試驗方案嚴重依賴生物樣本分析來滿足試驗終點。
  • 預計亞太地區在預測期內的增長率最快。 臨床試驗地點從歐洲和北美等西方地區向亞太地區轉移是該地區的主要促進因素。

內容

第 1 章調查方法及範圍

  • 市場細分和範圍
    • 服務
    • 階段
    • 產品類型
    • 區域範圍
  • 調查方法
  • 資訊採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要資訊
    • 初步調查
    • 初步調查的內容
  • 資訊或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細資訊
    • 商品流分析（模型 1）
  • 二級資訊列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第 3 章臨床試驗生物儲存庫和存檔解決方案市場：變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場展望
    • 輔助市場展望
  • 描繪滲透率和增長前景
  • 市場動態
    • 市場促進因素分析
      • 增加製藥和生物技術公司
      • 疾病變異和患病率增加
      • 增加研發投資
      • CRO 市場增長
    • 市場抑制因素分析
      • 新藥開發法規
      • 臨床試驗成本上升
  • 臨床試驗生物儲存庫和存檔解決方案市場分析工具
    • 波特的五力分析
    • PESTEL 分析
  • 主要交易和戰略聯盟
  • COVID-19 的影響

第 4 章臨床試驗生物資源庫和存檔解決方案市場：服務細分分析

  • 定義和範圍
  • 臨床試驗生物樣本庫和存檔解決方案：2022 年和 2030 年市場份額分析
  • 生物樣本庫服務
    • 倉庫存儲
    • 交通
    • 樣品處理
    • 其他
  • 歸檔解決方案服務
    • 數據庫索引和管理
    • 掃描並銷毀

第 5 章臨床試驗生物資源庫和存檔解決方案市場：產品類型細分分析

  • 定義和範圍
  • 臨床試驗生物樣本庫和存檔解決方案：2022 年和 2030 年市場份額分析
  • 臨床前產品
  • 臨床產品
    • 人體組織
    • 器官
    • 幹細胞
    • 其他生物樣本

第 6 章臨床試驗生物儲存庫和存檔解決方案市場：階段細分分析

  • 定義和範圍
  • 臨床試驗生物樣本庫和存檔解決方案：2022 年和 2030 年市場份額分析
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第 7 章臨床試驗生物儲存庫和存檔解決方案市場：區域分析

  • 臨床試驗生物樣本庫和存檔解決方案：2022 年和 2030 年市場份額分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
  • 多邊環境協定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第 8 章競爭格局

  • 公司簡介
    • Medpace
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • ATCC
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Cell&co BioServices
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Azenta US, Inc.
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Thermo Fisher Scientific Inc.（Patheon）
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Precision Medicine Group, LLC.
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Labcorp Drug Development
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Q2 Solutions
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • LabConnect
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Charles River Laboratories
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
Product Code: GVR-4-68039-532-8

Clinical Trial Biorepository & Archiving Solutions Market Growth & Trends:

The global clinical trial biorepository & archiving solutions market size is expected to reach USD 7.0 billion by 2030, registering a CAGR of 8.3%, from 2023 to 2030, according to a new report by Grand View Research, Inc. This is mainly due to the increasing importance of biological sample management in clinical trials and the desire to streamline data collection and reporting. In addition, the expansion of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data gathering & reporting easier by employing software like the Laboratory Information Management System (LIMS) to manage laboratory samples are all key factors driving the industry growth.

Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).

The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.

Clinical Trial Biorepository & Archiving Solutions Market Report Highlights:

  • The biorepository services segment dominated the industry in 2022 due to the rise in R&D of advanced therapies, such as personalized medicine, and the requirement of high-quality biorepository practices for the collection, processing, testing, and storage of samples
  • In terms of phase, the phase III segment dominated the industry in 2022 while the phase II segment is estimated to register the fastest CAGR from 2023 to 2030
  • The clinical products segment held the largest share in 2022 as most clinical trial protocols depend largely on the analysis of biological specimens to meet the study endpoints
  • Asia Pacific is anticipated to register the fastest growth rate over the forecast period. The shift of clinical trial sites from Western regions, such as Europe and North America, to Asia Pacific is a major factor driving the region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Service
    • 1.1.2 Phase
    • 1.1.3 Product Type
    • 1.1.4 Regional scope
    • 1.1.5 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR'S internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity flow analysis (Model 1)
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective - 1
    • 1.9.2 Objective - 2
    • 1.9.3 Objective - 3
    • 1.9.4 Objective - 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Clinical Trial Biorepository & Archiving Solutions Market: Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Growing number of pharmaceutical and biotechnology companies
      • 3.3.1.2 Growing disease variation and prevalence
      • 3.3.1.3 Increasing R&D investments
      • 3.3.1.4 Growth in the CRO market
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Regulations in new drug development
      • 3.3.2.2 Rising cost of clinical trials
  • 3.4 Clinical Trial Biorepository & Archiving Solutions Market Analysis Tools
    • 3.4.1 Porter's Five Forces analysis
    • 3.4.2 PESTEL analysis
  • 3.5 Major Deals & Strategic Alliances
  • 3.6 Covid-19 Impact

Chapter 4 Clinical Trial Biorepository & Archiving Solutions Market: Service Segment Analysis

  • 4.1 Definitions & Scope
  • 4.2 Clinical Trial Biorepository & Archiving Solutions: Market Share Analysis, 2022 & 2030
  • 4.3 Biorepository Services
    • 4.3.1 Biorepository services market, 2018 - 2030 (USD Million)
    • 4.3.2 Warehousing & storage
      • 4.3.2.1 Warehousing & storage market, 2018 - 2030 (USD Million)
    • 4.3.3 Transportation
      • 4.3.3.1 Transportation market, 2018 - 2030 (USD Million)
    • 4.3.4 Sample Processing
      • 4.3.4.1 Sample Processing market, 2018 - 2030 (USD Million)
    • 4.3.5 Others
      • 4.3.5.1 Others market, 2018 - 2030 (USD Million)
  • 4.4 Archiving Solution Services
    • 4.4.1 Archiving Solution Services market, 2018 - 2030 (USD Million)
    • 4.4.2 Database Indexing and Management
      • 4.4.2.1 Database Indexing and Management market, 2018 - 2030 (USD Million)
    • 4.4.3 Scanning & Destruction
      • 4.4.3.1 Scanning & Destruction, 2018 - 2030 (USD Million)

Chapter 5 Clinical Trial Biorepository & Archiving Solutions Market: Product Type Segment Analysis

  • 5.1 Definitions & Scope
  • 5.2 Clinical Trial Biorepository & Archiving Solutions: Market Share Analysis, 2022 & 2030
  • 5.3 Preclinical Products
    • 5.3.1 Preclinical ProductsMarket, 2018 - 2030 (USD Million)
  • 5.4 Clinical Products
    • 5.4.1 Clinical Products market, 2018 - 2030 (USD Million)
    • 5.4.2 Human Tissue
      • 5.4.2.1 Human Tissue market, 2018 - 2030 (USD Million)
    • 5.4.3 Organs
      • 5.4.3.1 Organs market, 2018 - 2030 (USD Million)
    • 5.4.4 Stem cells
      • 5.4.4.1 Stem cells market, 2018 - 2030 (USD Million)
    • 5.4.5 Other biospecimens
      • 5.4.5.1 Other biospecimens market, 2018 - 2030 (USD Million)

Chapter 6 Clinical Trial Biorepository & Archiving Solutions Market: Phase Segment Analysis

  • 6.1 Definitions & Scope
  • 6.2 Clinical Trial Biorepository & Archiving Solutions: Market Share Analysis, 2022 & 2030
  • 6.3 Phase I
    • 6.2.1 Phase I Market, 2018 - 2030 (USD Million)
  • 6.4 Phase II
    • 6.3.1 Phase II market, 2018 - 2030 (USD Million)
  • 6.5 Phase III
    • 6.4.1 Phase III market, 2018 - 2030 (USD Million)
  • 6.6 Phase IV
    • 6.5.1 Phase IV market, 2018 - 2030 (USD Million)

Chapter 7 Clinical Trial Biorepository & Archiving Solutions Market: Regional Analysis

  • 7.1 Clinical Trial Biorepository & Archiving Solutions: Market Share Analysis, 2022 & 2030
  • 7.2 North America
    • 7.2.1 North America clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.2 U.K.
      • 7.3.2.1 U.K. clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Italy clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Spain clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.7 Sweden
      • 7.3.7.1 Sweden clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.8 Denmark
      • 7.3.8.1 Denmark clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.9 Norway
      • 7.3.9.1 Norway clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 India clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.4.5 Australia
      • 7.4.5.1 Australia clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.4.6 South Korea
      • 7.4.6.1 South Korea clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.4.7 Thailand
      • 7.4.7.1 Thailand clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.5.5 Colombia
      • 7.5.5.1 Colombia clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 UAE clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.6.5 Kuwait

Chapter 8 Competitive Landscape

  • 8.1 Company Profiles
    • 8.1.1 Medpace
      • 8.1.1.1 Company overview
      • 8.1.1.2 Financial performance
      • 8.1.1.3 Service benchmarking
      • 8.1.1.4 Strategic Initiatives
    • 8.1.2 ATCC
      • 8.1.2.1 Company overview
      • 8.1.2.2 Financial performance
      • 8.1.2.3 Service benchmarking
      • 8.1.2.4 Strategic Initiatives
    • 8.1.3 Cell&co BioServices
      • 8.1.3.1 Company overview
      • 8.1.3.2 Financial performance
      • 8.1.3.3 Service benchmarking
      • 8.1.3.4 Strategic Initiatives
    • 8.1.4 Azenta US, Inc.
      • 8.1.4.1 Company overview
      • 8.1.4.2 Financial performance
      • 8.1.4.3 Service benchmarking
      • 8.1.4.4 Strategic Initiatives
    • 8.1.5 Thermo Fisher Scientific Inc. (Patheon)
      • 8.1.4.1 Company overview
      • 8.1.4.2 Financial performance
      • 8.1.4.3 Service benchmarking
      • 8.1.4.4 Strategic Initiatives
    • 8.1.6 Precision Medicine Group, LLC.
      • 8.1.6.1 Company overview
      • 8.1.6.2 Financial performance
      • 8.1.6.3 Service benchmarking
      • 8.1.6.4 Strategic Initiatives
    • 8.1.7 Labcorp Drug Development
      • 8.1.7.1 Company overview
      • 8.1.7.2 Financial performance
      • 8.1.7.3 Service benchmarking
      • 8.1.7.4 Strategic Initiatives
    • 8.1.8 Q2 Solutions
      • 8.1.8.1 Company overview
      • 8.1.8.2 Financial performance
      • 8.1.8.3 Service benchmarking
      • 8.1.8.4 Strategic Initiatives
    • 8.1.9 LabConnect
      • 8.1.9.1 Company overview
      • 8.1.9.2 Financial performance
      • 8.1.9.3 Service benchmarking
      • 8.1.9.4 Strategic Initiatives
    • 8.1.10 Charles River Laboratories
      • 8.1.10.1 Company overview
      • 8.1.10.2 Financial performance
      • 8.1.10.3 Service benchmarking
      • 8.1.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Clinical trial biorepository & archiving solutions market snapshot (2022)
  • Fig. 9 clinical trial biorepository & archiving solutions market segmentation
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 17 Clinical trial biorepository & archiving solutions market service: Segment dashboard
  • Fig. 18 Clinical trial biorepository & archiving solutions market: Service movement analysis
  • Fig. 19 Biorepository services market, 2018 - 2030 (USD Million)
  • Fig. 20 Warehousing & storage market, 2018 - 2030 (USD Million)
  • Fig. 21 Transportation market, 2018 - 2030 (USD Million)
  • Fig. 22 Sample Processing market, 2018 - 2030 (USD Million)
  • Fig. 23 Others market, 2018 - 2030 (USD Million)
  • Fig. 24 Archiving solution services market, 2018 - 2030 (USD Million)
  • Fig. 25 Database indexing and management market, 2018 - 2030 (USD Million)
  • Fig. 26 Scanning & destruction market, 2018 - 2030 (USD Million)
  • Fig. 27 Clinical trial biorepository & archiving solutions market product type outlook: Segment dashboard
  • Fig. 28 Clinical trial biorepository & archiving solutions market: Product type movement analysis
  • Fig. 29 Preclinical products market, 2018 - 2030 (USD Million)
  • Fig. 30 Clinical products market, 2018 - 2030 (USD Million)
  • Fig. 31 Human tissue market, 2018 - 2030 (USD Million)
  • Fig. 32 Organs market, 2018 - 2030 (USD Million)
  • Fig. 33 Stem cells market, 2018 - 2030 (USD Million)
  • Fig. 34 Other biospecimens market, 2018 - 2030 (USD Million)
  • Fig. 35 Clinical trial biorepository & archiving solutions market phase outlook: Segment dashboard
  • Fig. 36 Clinical trial biorepository & archiving solutions market: Phase movement analysis
  • Fig. 37 Phase I market, 2018 - 2030 (USD Million)
  • Fig. 38 Phase II market, 2018 - 2030 (USD Million)
  • Fig. 39 Phase III market, 2018 - 2030 (USD Million)
  • Fig. 40 Phase IV market, 2018 - 2030 (USD Million)
  • Fig. 41 Regional market: Key takeaways
  • Fig. 42 Regional outlook, 2022 2030
  • Fig. 43 North America market, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 45 Canada market, 2018 - 2030 (USD Million)
  • Fig. 46 Europe market, 2018 - 2030 (USD Million)
  • Fig. 47 U.K. market, 2018 - 2030 (USD Million)
  • Fig. 48 Germany market, 2018 - 2030 (USD Million)
  • Fig. 49 France market, 2018 - 2030 (USD Million)
  • Fig. 50 Italy market, 2018 - 2030 (USD Million)
  • Fig. 51 Spain market, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden market, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark market, 2018 - 2030 (USD Million)
  • Fig. 54 Norway market, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan market, 2018 - 2030 (USD Million)
  • Fig. 57 China market, 2018 - 2030 (USD Million)
  • Fig. 58 India market, 2018 - 2030 (USD Million)
  • Fig. 59 Australia market, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 64 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 66 Colombia market, 2018 - 2030 (USD Million)
  • Fig. 67 MEA market, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 70 UAE market, 2018 - 2030 (USD Million)
  • Fig. 71 Kuwait market, 2018 - 2030 (USD Million)